[go: up one dir, main page]

SE503508C2 - Dosform för avgivande av diltiazem - Google Patents

Dosform för avgivande av diltiazem

Info

Publication number
SE503508C2
SE503508C2 SE8803085A SE8803085A SE503508C2 SE 503508 C2 SE503508 C2 SE 503508C2 SE 8803085 A SE8803085 A SE 8803085A SE 8803085 A SE8803085 A SE 8803085A SE 503508 C2 SE503508 C2 SE 503508C2
Authority
SE
Sweden
Prior art keywords
diltiazem
weight
wall
composition
molecular weight
Prior art date
Application number
SE8803085A
Other languages
English (en)
Swedish (sv)
Other versions
SE8803085L (sv
SE8803085D0 (sv
Inventor
Patrick S-L Wong
Felix Theeuwes
George V Guittard
Richard Cortese
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of SE8803085D0 publication Critical patent/SE8803085D0/xx
Publication of SE8803085L publication Critical patent/SE8803085L/
Publication of SE503508C2 publication Critical patent/SE503508C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8803085A 1988-06-02 1988-09-02 Dosform för avgivande av diltiazem SE503508C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/201,519 US4859470A (en) 1988-06-02 1988-06-02 Dosage form for delivering diltiazem

Publications (3)

Publication Number Publication Date
SE8803085D0 SE8803085D0 (sv) 1988-09-02
SE8803085L SE8803085L (sv) 1989-12-03
SE503508C2 true SE503508C2 (sv) 1996-06-24

Family

ID=22746162

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8803085A SE503508C2 (sv) 1988-06-02 1988-09-02 Dosform för avgivande av diltiazem

Country Status (25)

Country Link
US (1) US4859470A (fr)
JP (1) JP2590226B2 (fr)
KR (1) KR960006062B1 (fr)
AR (1) AR241635A1 (fr)
AT (1) AT394311B (fr)
AU (1) AU612398B2 (fr)
BE (1) BE1001935A3 (fr)
CA (1) CA1311687C (fr)
CH (1) CH675208A5 (fr)
DE (1) DE3829941C2 (fr)
DK (1) DK175396B1 (fr)
ES (1) ES2008813A6 (fr)
FI (1) FI92553C (fr)
FR (1) FR2632306B1 (fr)
GB (1) GB2219205B (fr)
GR (1) GR1000197B (fr)
IE (1) IE61861B1 (fr)
IT (1) IT1223799B (fr)
LU (1) LU87327A1 (fr)
MX (1) MX174157B (fr)
NL (1) NL194747C (fr)
NO (1) NO174766C (fr)
PT (1) PT88405B (fr)
SE (1) SE503508C2 (fr)
ZA (1) ZA886436B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5112614A (en) * 1989-09-14 1992-05-12 Alza Corporation Implantable delivery dispenser
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US6562375B1 (en) 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
WO2001010466A1 (fr) * 1999-08-04 2001-02-15 Yamanouchi Pharmaceutical Co., Ltd. Compositions medicinales stables pour administration orale
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
AR040682A1 (es) * 2002-07-25 2005-04-13 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
NZ553645A (en) 2004-08-13 2010-09-30 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
JP4785847B2 (ja) 2004-08-13 2011-10-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング プラミペキソール又はその医薬品として許容される塩を含む放出が延長された錠剤調合物、その製造方法及びその使用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
EP0205336B1 (fr) * 1985-06-11 1991-09-11 Teijin Limited Préparation pharmaceutique orale à effet entretenn
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form
ATE75394T1 (de) * 1986-11-14 1992-05-15 Ciba Geigy Ag Orales osmotisches system fuer metoprolol mit verbesserten formulierungseigenschaften.

Also Published As

Publication number Publication date
FI92553C (fi) 1994-12-12
KR900000076A (ko) 1990-01-30
JP2590226B2 (ja) 1997-03-12
DE3829941A1 (de) 1989-12-14
GR880100574A (en) 1990-05-11
FI884057A0 (fi) 1988-09-02
NO883838D0 (no) 1988-08-29
CH675208A5 (fr) 1990-09-14
NL194747B (nl) 2002-10-01
IT8867791A0 (it) 1988-09-02
FI92553B (fi) 1994-08-31
NL8802181A (nl) 1990-01-02
DE3829941C2 (de) 1997-07-03
US4859470A (en) 1989-08-22
IE882642L (en) 1989-12-02
JPH01313432A (ja) 1989-12-18
AU612398B2 (en) 1991-07-11
CA1311687C (fr) 1992-12-22
ES2008813A6 (es) 1989-08-01
ATA214588A (de) 1991-09-15
LU87327A1 (fr) 1989-03-08
SE8803085L (sv) 1989-12-03
NO174766B (no) 1994-03-28
DK175396B1 (da) 2004-09-27
GB2219205B (en) 1992-07-15
IE61861B1 (en) 1994-11-30
GB8820461D0 (en) 1988-09-28
AR241635A1 (es) 1992-10-30
NO883838L (no) 1989-12-04
SE8803085D0 (sv) 1988-09-02
NL194747C (nl) 2003-02-04
FI884057A (fi) 1989-12-03
AT394311B (de) 1992-03-10
DK485688A (da) 1989-12-03
DK485688D0 (da) 1988-09-01
PT88405A (pt) 1990-06-29
AU2152788A (en) 1989-12-07
GB2219205A (en) 1989-12-06
FR2632306B1 (fr) 1990-11-16
BE1001935A3 (fr) 1990-04-17
KR960006062B1 (ko) 1996-05-08
FR2632306A1 (fr) 1989-12-08
IT1223799B (it) 1990-09-29
MX174157B (es) 1994-04-25
ZA886436B (en) 1989-05-30
NO174766C (no) 1994-07-06
PT88405B (pt) 1995-07-18
GR1000197B (el) 1992-03-20

Similar Documents

Publication Publication Date Title
SE503508C2 (sv) Dosform för avgivande av diltiazem
US4915952A (en) Composition comprising drug, HPC, HPMC and PEO
KR0125935B1 (ko) 코어막 밀착 특성이 향상된, 약제학적으로 허용되는 활성 성분을 함유하는 삼투성 연속 분배 경구 전달 시스템
CA1257167A (fr) Dispositif pour la distribution de medicaments suivant un cycle prevu
JP5143324B2 (ja) 長期放出剤形
CN101375869B (zh) 含银杏叶提取物缓/控释微丸组合物及其制备方法
US4810502A (en) Pseudoephedrine brompheniramine therapy
JPS61249917A (ja) 薬剤放出開始時期を制御する手段を備えた浸透圧利用薬剤投与具
JPH085777B2 (ja) 溶解度制御手段を有する投与用製剤
SE503471C2 (sv) Osmotisk dosform innehållande isradipin
JPS6344516A (ja) 酸に敏感な有用な薬剤を送給放出し得る投与用製剤
JPS61249916A (ja) 不活性なコア部を有する浸透圧利用薬剤投与具
BG63152B1 (bg) Дозирани форми с контролирано освобождаване на азитромицин
JPS61185272A (ja) 脂質浸透ポンプ
SK455990A3 (en) Pharmaceutical delivery systems and methods of preparation thereof
JP2002528487A5 (fr)
EP0238189A1 (fr) Verapamil en capsule de diffusion
CA2000932C (fr) Forme pharmaceutique orale multiparticulaire a liberation controlee
US4966769A (en) Method for delivering dosage form for diltiazem
JPS632920A (ja) ガス生成速度制御手段を有する投与用製剤
JPH02504145A (ja) 酵素制御薬物放出性ペレット
KR100527335B1 (ko) 서방형 약물 전달 기구
JP2002514592A (ja) 抗うつ剤療法
US5023076A (en) Lamina comprising carboxyvinyl polymer
CN112741806A (zh) 一种用于老年痴呆症的缓控释给药系统

Legal Events

Date Code Title Description
NUG Patent has lapsed